Tetrahydro-benzoazepine glycosidase inhibitors
US11795165B2 · kind B2 · utility
5Cited by
21References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2019 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Oct 21, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I′), wherein A, R1, R2, T1, T2, T3, T4, L, W, Z, R′″, m and n have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.